 Hematopoietic Stem Cell Transplantation
"Hematopoietic Stem Cell Transplantation" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Transfer of HEMATOPOIETIC STEM CELLS from BONE MARROW or BLOOD between individuals within the same species (TRANSPLANTATION, HOMOLOGOUS) or transfer within the same individual (TRANSPLANTATION, AUTOLOGOUS). Hematopoietic stem cell transplantation has been used as an alternative to BONE MARROW TRANSPLANTATION in the treatment of a variety of neoplasms.
| Descriptor ID |
D018380
|
| MeSH Number(s) |
E04.936.225.687.500
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Hematopoietic Stem Cell Transplantation".
Below are MeSH descriptors whose meaning is more specific than "Hematopoietic Stem Cell Transplantation".
This graph shows the total number of publications written about "Hematopoietic Stem Cell Transplantation" by people in this website by year, and whether "Hematopoietic Stem Cell Transplantation" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1990 | 3 | 0 | 3 | | 1993 | 2 | 0 | 2 | | 1994 | 1 | 0 | 1 | | 1995 | 3 | 1 | 4 | | 1996 | 6 | 2 | 8 | | 1997 | 14 | 0 | 14 | | 1998 | 11 | 0 | 11 | | 1999 | 14 | 1 | 15 | | 2000 | 12 | 2 | 14 | | 2001 | 9 | 7 | 16 | | 2002 | 8 | 3 | 11 | | 2003 | 8 | 5 | 13 | | 2004 | 14 | 5 | 19 | | 2005 | 10 | 1 | 11 | | 2006 | 12 | 5 | 17 | | 2007 | 15 | 3 | 18 | | 2008 | 15 | 8 | 23 | | 2009 | 21 | 9 | 30 | | 2010 | 26 | 5 | 31 | | 2011 | 16 | 3 | 19 | | 2012 | 18 | 5 | 23 | | 2013 | 26 | 4 | 30 | | 2014 | 22 | 5 | 27 | | 2015 | 17 | 2 | 19 | | 2016 | 17 | 8 | 25 | | 2017 | 19 | 8 | 27 | | 2018 | 14 | 5 | 19 | | 2019 | 22 | 7 | 29 | | 2020 | 30 | 5 | 35 | | 2021 | 6 | 2 | 8 |
To return to the timeline, click here.
Below are the most recent publications written about "Hematopoietic Stem Cell Transplantation" by people in Profiles.
-
Lacy M, Fong M, Bolton C, Maranzano M, Bishop M, Artz A. Cognitive functioning of older adults prior to hematopoietic stem cell transplantation. Bone Marrow Transplant. 2021 10; 56(10):2575-2581.
-
Badar T, Szabo A, Litzow M, Burkart M, Yurkiewicz I, Dinner S, Hefazi M, Shallis RM, Podoltsev N, Patel AA, Curran E, Wadleigh M, Balasubramanian S, Yang J, Arslan S, Aldoss I, Mattison R, Cenin D, Siebenaller C, Advani A, Liedtke M, Atallah E. Multi-institutional study evaluating clinical outcome with allogeneic hematopoietic stem cell transplantation after blinatumomab in patients with B-cell acute lymphoblastic leukemia: real-world data. Bone Marrow Transplant. 2021 08; 56(8):1998-2004.
-
Wieduwilt MJ, Stock W, Advani A, Luger S, Larson RA, Tallman M, Appelbaum F, Zhang MJ, Bo-Subait K, Wang HL, Bhatt VR, Dholaria B, Eapen M, Hamadani M, Jamy O, Prestidge T, Pulsipher M, Ritchie D, Rizzieri D, Sharma A, Barba P, Sandmaier BM, de Lima M, Kebriaei P, Litzow M, Saber W, Weisdorf D. Superior survival with pediatric-style chemotherapy compared to myeloablative allogeneic hematopoietic cell transplantation in older adolescents and young adults with Ph-negative acute lymphoblastic leukemia in first complete remission: analysis from CALGB 10403 and the CIBMTR. Leukemia. 2021 07; 35(7):2076-2085.
-
Khan N, Lindner S, Gomes ALC, Devlin SM, Shah GL, Sung AD, Sauter CS, Landau HJ, Dahi PB, Perales MA, Chung DJ, Lesokhin AM, Dai A, Clurman A, Slingerland JB, Slingerland AE, Brereton DG, Giardina PA, Maloy M, Armijo GK, Rondon-Clavo C, Fontana E, Bohannon L, Ramalingam S, Bush AT, Lew MV, Messina JA, Littmann E, Taur Y, Jenq RR, Chao NJ, Giralt S, Markey KA, Pamer EG, van den Brink MRM, Peled JU. Fecal microbiota diversity disruption and clinical outcomes after auto-HCT: a multicenter observational study. Blood. 2021 03 18; 137(11):1527-1537.
-
Liao C, Taylor BP, Ceccarani C, Fontana E, Amoretti LA, Wright RJ, Gomes ALC, Peled JU, Taur Y, Perales MA, van den Brink MRM, Littmann E, Pamer EG, Schluter J, Xavier JB. Compilation of longitudinal microbiota data and hospitalome from hematopoietic cell transplantation patients. Sci Data. 2021 03 02; 8(1):71.
-
Ragoonanan D, Khazal SJ, Abdel-Azim H, McCall D, Cuglievan B, Tambaro FP, Ahmad AH, Rowan CM, Gutierrez C, Schadler K, Li S, Di Nardo M, Chi L, Gulbis AM, Shoberu B, Mireles ME, McArthur J, Kapoor N, Miller J, Fitzgerald JC, Tewari P, Petropoulos D, Gill JB, Duncan CN, Lehmann LE, Hingorani S, Angelo JR, Swinford RD, Steiner ME, Hernandez Tejada FN, Martin PL, Auletta J, Choi SW, Bajwa R, Dailey Garnes N, Kebriaei P, Rezvani K, Wierda WG, Neelapu SS, Shpall EJ, Corbacioglu S, Mahadeo KM. Diagnosis, grading and management of toxicities from immunotherapies in children, adolescents and young adults with cancer. Nat Rev Clin Oncol. 2021 07; 18(7):435-453.
-
Nawas MT, Shah GL, Feldman DR, Ruiz JD, Robilotti EV, Aslam AA, Dundas M, Kamboj M, Barker JN, Cho C, Chung DJ, Dahi PB, Giralt SA, Gyurkocza B, Lahoud OB, Landau HJ, Lin RJ, Mailankody S, Palomba ML, Papadopoulos EB, Politikos I, Ponce DM, Sauter CS, Shaffer BC, Scordo M, van den Brink MRM, Perales MA, Tamari R. Cellular Therapy During COVID-19: Lessons Learned and Preparing for Subsequent Waves. Transplant Cell Ther. 2021 05; 27(5):438.e1-438.e6.
-
Derman BA, Stefka AT, Jiang K, McIver A, Kubicki T, Jasielec JK, Jakubowiak AJ. Measurable residual disease assessed by mass spectrometry in peripheral blood in multiple myeloma in a phase II trial of carfilzomib, lenalidomide, dexamethasone and autologous stem cell transplantation. Blood Cancer J. 2021 02 05; 11(2):19.
-
Chemaly RF, Dadwal SS, Bergeron A, Ljungman P, Kim YJ, Cheng GS, Pipavath SN, Limaye AP, Blanchard E, Winston DJ, Stiff PJ, Zuckerman T, Lachance S, Rahav G, Small CB, Mullane KM, Patron RL, Lee DG, Hirsch HH, Waghmare A, McKevitt M, Jordan R, Guo Y, German P, Porter DP, Gossage DL, Watkins TR, Marty FM, Chien JW, Boeckh M. A Phase 2, Randomized, Double-blind, Placebo-Controlled Trial of Presatovir for the Treatment of Respiratory Syncytial Virus Upper Respiratory Tract Infection in Hematopoietic-Cell Transplant Recipients. Clin Infect Dis. 2020 12 31; 71(11):2777-2786.
-
Marty FM, Chemaly RF, Mullane KM, Lee DG, Hirsch HH, Small CB, Bergeron A, Shoham S, Ljungman P, Waghmare A, Blanchard E, Kim YJ, McKevitt M, Porter DP, Jordan R, Guo Y, German P, Boeckh M, Watkins TR, Chien JW, Dadwal SS. A Phase 2b, Randomized, Double-blind, Placebo-Controlled Multicenter Study Evaluating Antiviral Effects, Pharmacokinetics, Safety, and Tolerability of Presatovir in Hematopoietic Cell Transplant Recipients with Respiratory Syncytial Virus Infection of the Lower Respiratory Tract. Clin Infect Dis. 2020 12 31; 71(11):2787-2795.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|